MetLife, Inc. (NYSE:MET) Receives $94.18 Average Target Price from Analysts

Shares of MetLife, Inc. (NYSE:MET) have been assigned a consensus recommendation of “Buy” from the thirteen brokerages that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $94.1818.

MET has been the subject of several recent analyst reports. Wells Fargo & Company decreased their target price on shares of MetLife from $97.00 to $93.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. Keefe, Bruyette & Woods reduced their price target on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a research report on Tuesday, November 11th. UBS Group raised their price objective on shares of MetLife from $94.00 to $98.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Weiss Ratings upgraded shares of MetLife from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 20th. Finally, Barclays set a $90.00 target price on MetLife in a report on Thursday, January 8th.

MetLife Stock Performance

NYSE:MET opened at $71.83 on Wednesday. The company has a 50-day moving average of $77.20 and a 200-day moving average of $78.72. The firm has a market cap of $46.84 billion, a price-to-earnings ratio of 15.28, a price-to-earnings-growth ratio of 0.67 and a beta of 0.76. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52. MetLife has a twelve month low of $65.21 and a twelve month high of $85.00.

MetLife (NYSE:MET) last released its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 EPS for the quarter, beating the consensus estimate of $2.34 by $0.15. The business had revenue of $52.44 billion during the quarter, compared to analyst estimates of $31.43 billion. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The business’s quarterly revenue was up 27.6% on a year-over-year basis. During the same period in the prior year, the business earned $2.08 earnings per share. Analysts forecast that MetLife will post 9.65 earnings per share for the current fiscal year.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd will be paid a $0.5675 dividend. This represents a $2.27 annualized dividend and a yield of 3.2%. The ex-dividend date of this dividend is Tuesday, February 3rd. MetLife’s dividend payout ratio is currently 48.30%.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife confirmed its previously announced Q1 2026 dividend on its Series A floating-rate preferred shares, $0.31501229 per share, signaling consistency in capital returns for preferred holders and helping support yield-sensitive investors. Article Title
• Positive Sentiment: MetLife and partner Crow Holdings completed the sale/trade of 210 multifamily units in Tampa — an example of active portfolio management that can free capital or crystallize gains from real-estate holdings. Article Title
• Neutral Sentiment: MetLife GCC leased ~75,000 sq ft in Noida’s Oxygen Business Park — a regional expansion/lease that speaks to business presence in India but is unlikely to move the stock materially in the near term. Article Title
• Neutral Sentiment: High-profile events at MetLife Stadium (temporary renaming/World Cup hosting coverage, ticket guides) increase brand visibility and venue revenue potential, but these items are peripheral to core insurance fundamentals. Article Title
• Neutral Sentiment: A recent piece comparing MetLife’s stock performance to peers provides context for relative valuation and momentum; useful for investors but not a direct catalyst. Article Title
• Negative Sentiment: Morgan Stanley published a pessimistic forecast for MET, which likely contributed to selling pressure and the intraday decline — analyst downgrades/price-target cuts are common drivers of short-term stock weakness. Article Title

Hedge Funds Weigh In On MetLife

Institutional investors and hedge funds have recently modified their holdings of the stock. Activest Wealth Management raised its holdings in shares of MetLife by 205.8% during the fourth quarter. Activest Wealth Management now owns 315 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 212 shares in the last quarter. Vermillion & White Wealth Management Group LLC boosted its position in MetLife by 790.0% during the third quarter. Vermillion & White Wealth Management Group LLC now owns 356 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 316 shares during the last quarter. Sound Income Strategies LLC grew its stake in MetLife by 58.9% in the fourth quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 142 shares in the last quarter. Garton & Associates Financial Advisors LLC acquired a new position in MetLife in the 4th quarter worth about $30,000. Finally, Gunpowder Capital Management LLC dba Oliver Wealth Management acquired a new position in MetLife in the 4th quarter worth about $31,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.